Nishida Sumiyuki 西田純幸

… Alternative Names

NISHIDA Sumiyuki 西田純幸

Less

Researcher Number	00403189
Other IDs
Affiliation (Current)	2025: 大阪大学, 大学院医学系研究科, 特任教授(常勤)
Affiliation (based on the past Project Information) *help	2022 – 2023: 大阪大学, 大学院医学系研究科, 特任教授(常勤) 2020 – 2021: 大阪大学, 医学系研究科, 講師 2016 – 2019: 大阪大学, 医学系研究科, 助教 2011: 大阪大学, 大学院・医学系研究科, 寄附講座助教 2008 – 2011: Osaka University, 医学系研究科, 寄附講座助教 2008: Osaka University, 医学系研究科, 寄附講座助教授 2007: Osaka University, 医学糸研究科, 寄附講座助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Obstetrics and gynecology / Gastroenterology / Hematology
Keywords	Principal Investigator WT1 / がんワクチン / がん免疫療法 / 細胞傷害性T細胞 / 膵臓がん / high-avidity TCR / CTL / がんワクチン療法 / single cell RNAseq / TCRレパトア … More / T細胞受容体 / 婦人科腫瘍学 / WT1ペプチドワクチン / 卵巣癌 / 抗原特異的T細胞 / 卵巣がん / 細胞障害性リンパ球 / 細胞傷害性リンパ球 / 癌免疫療法 / 膵臓癌 / 膵臓学(膵臓癌) / 胆道学 / 白血病 / 造血幹細胞 Less

難治がんに有望ながん免疫effector T細胞特性の基盤的解明と細胞治療開発Principal Investigator
- Principal Investigator
  
  西田純幸
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Osaka University
Cellular and Molecular analyses of cancer-associated antigen-specific cytotoxic T cells by multidimensional methods and development of novel cancer immunotherapyPrincipal Investigator
- Principal Investigator
  
  Nishida Sumiyuki
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Osaka University
Development of WT1 peptide vaccine for ovarian cancer and analyses of WT1-CTLsPrincipal Investigator
- Principal Investigator
  
  Nishida Sumiyuki
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Obstetrics and gynecology
- Research Institution
  Osaka University
WT1-specific immunological assessments in WT1-peptide-based cancer vaccine in combination with gemcitabine for patients with advanced pancreatic cancerPrincipal Investigator
- Principal Investigator
  
  NISHIDA Sumiyuki
- Project Period (FY)
  2009 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Osaka University
Overexpression of the WT1 gene effects on proliferation ofhematopoietic stem cells, and promotes leukemogenesisPrincipal Investigator
- Principal Investigator
  
  NISHIDA Sumiyuki
- Project Period (FY)
  2007 – 2008
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Hematology
- Research Institution
  Osaka University

All 2023 2022 2021 2019 2018 2017 2016 2012 2011 2010 2009

All Journal Article Presentation

[Journal Article] Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs2023
- Author(s)
  Fujiki Fumihiro、Morimoto Soyoko、Nishida Yuya、Tanii Satoe、Aoyama Nao、Inatome Miki、Inoue Kento、Katsuhara Akiko、Nakajima Hiroko、Nakata Jun、Nishida Sumiyuki、Tsuboi Akihiro、Oka Yoshihiro、Oji Yusuke、Sogo Shinji、Sugiyama Haruo
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: in press Issue: 7 Pages: 2347-2356
- DOI
  10.1007/s00262-023-03420-8
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07251, KAKENHI-PROJECT-23K06761, KAKENHI-PROJECT-23K21389
[Journal Article] Bayesian predictive model averaging approach to joint longitudinal-survival modeling: Application to an immuno-oncology clinical trial.2023
- Author(s)
  Yao Zixuan、Morita Satoshi、Nishida Sumiyuki、Sugiyama Haruo
- Journal Title
  
  Statistics in Medicine
  
  Volume: 42 Issue: 27 Pages: 4990-5006
- DOI
  10.1002/sim.9897
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07251
[Journal Article] WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT12023
- Author(s)
  Oji Y, Kagawa N, Arita H, Naka N, Hamada KI, Outani H, Shintani Y, Takeda Y, Morii E, Shimazu K, Suzuki M, Nishida S, Nakata J, Tsuboi A, Iwai M, Hayashi S, Imanishi R, Ikejima S, Kanegae M, Iwamoto M, Ikeda M, Yagi K, Shimokado H, Nakajima H, Hasegawa K, Morimoto S, Fujiki F　他
- Journal Title
  
  Cancers
  
  Volume: 15 Issue: 2 Pages: 393-393
- DOI
  10.3390/cancers15020393
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07251, KAKENHI-PROJECT-19K08650, KAKENHI-PROJECT-20K08732, KAKENHI-PROJECT-22K09283, KAKENHI-PROJECT-23K06761, KAKENHI-PROJECT-19K09457
[Journal Article] Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer.2022
- Author(s)
  Nishida S, Morimoto S, Oji Y, Morita S, Shirakata T, Enomoto T, Tsuboi A, Ueda Y, Yoshino K, Shouq A, Kanegae M, Ohno S, Fujiki F, Nakajima H, Nakae Y, Nakata J, Hosen N, Kumanogoh A, Oka Y, Kimura T, Sugiyama H.
- Journal Title
  
  J Immunother.
  
  Volume: 45 Issue: 1 Pages: 55-66
- DOI
  10.1097/cji.0000000000000405
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07729, KAKENHI-PROJECT-20K07695
[Journal Article] WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine.2022
- Author(s)
  Alzaaqi S, Naka N, Hamada K, Hosen N, Kanegae M, Outani H, Adachi M, Imanishi R, Morii E, Iwai M, Nakata J, Fujiki F, Morimoto S, Nakajima H, Nishida S, Tsuboi A, Oka Y, Sugiyama H, Oji Y.
- Journal Title
  
  Oncol Lett.
  
  Volume: - Issue: 2
- DOI
  10.3892/ol.2022.13184
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07729
[Journal Article] T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy2022
- Author(s)
  Fujiki Fumihiro、Morimoto Soyoko、Katsuhara Akiko、Okuda Akane、Ogawa Saeka、Ueda Eriko、Miyazaki Maki、Isotani Ayako、Ikawa Masahito、Nishida Sumiyuki、Nakajima Hiroko、Tsuboi Akihiro、Oka Yoshihiro、Nakata Jun、Hosen Naoki、Kumanogoh Atsushi、Oji Yusuke、Sugiyama Haruo
- Journal Title
  
  Frontiers in Immunology
  
  Volume: 13 Pages: 935465-935465
- DOI
  10.3389/fimmu.2022.935465
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K07251, KAKENHI-PROJECT-23K21389
[Journal Article] Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides.2021
- Author(s)
  Fujiki F, Tsuboi A, Morimoto S, Hashimoto N, Inatome M, Nakajima H, Nakata J, Nishida S, Hasegawa K, Hosen N, Oka Y, Oji Y, Sogo S, Sugiyama H.
- Journal Title
  
  Cancer Immunol Immunother.
  
  Volume: 70 Issue: 1 Pages: 253-263
- DOI
  10.1007/s00262-020-02675-9
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07729, KAKENHI-PROJECT-20K07695
[Journal Article] Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.2019
- Author(s)
  Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y, Kumanogoh A, Kawase I, Oka Y, Azuma I, Morita S, Sugiyama H.
- Journal Title
  
  Medicine (Baltimore)
  
  Volume: 98 Issue: 33 Pages: e16771-e16771
- DOI
  10.1097/md.0000000000016771
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07729, KAKENHI-PROJECT-17K07215, KAKENHI-PROJECT-17K07216
[Journal Article] WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies2018
- Author(s)
  Oji Y、Inoue M、Takeda Y、Hosen N、Shintani Y、Kawakami M、Harada T、Murakami Y、Iwai M、Fukuda M、Nishida S、Nakata J、Nakae Y、Takashima S、Shirakata T、Nakajima H、Hasegawa K、Kida H、Kijima T、Morimoto S、Fujiki F、Tsuboi A、Morii E、Morita S、Sakamoto J、Kumanogoh A、Oka Y、Okumura M、Sugiyama H
- Journal Title
  
  International Journal of Cancer
  
  Volume: 142 Issue: 11 Pages: 2375-2382
- DOI
  10.1002/ijc.31253
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K09537, KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-17K07215, KAKENHI-PROJECT-17K07216, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K09476
[Journal Article] Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity2018
- Author(s)
  Morimoto Soyoko、Fujiki Fumihiro、Kondo Kenta、Nakajima Hiroko、Kobayashi Yoshiki、Inatome Miki、Aoyama Nao、Nishida Yuya、Tsuboi Akihiro、Oka Yoshihiro、Nishida Sumiyuki、Nakata Jun、Hosen Naoki、Oji Yusuke、Sugiyama Haruo
- Journal Title
  
  Oncotarget
  
  Volume: 9 Issue: 75 Pages: 34132-34141
- DOI
  10.18632/oncotarget.26139
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K07215, KAKENHI-PROJECT-17K07216, KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-17K15727
[Journal Article] Combination Gemcitabine and WT1 Peptide Vaccination Improves Progression-Free Survival in Advanced Pancreatic Ductal Adenocarcinoma: A Phase II Randomized Study.2018
- Author(s)
  Nishida S, Ishikawa T, Egawa S, Koido S, Yanagimoto H, Ishii J, Kanno Y, Kokura S, Yasuda H, Oba MS, Sato M, Morimoto S, Fujiki F, Eguchi H, Nagano H, Kumanogoh A, Unno M, Kon M, Shimada H, Ito K, Homma S, Oka Y, Morita S, Sugiyama H.
- Journal Title
  
  Cancer Immunol Res.
  
  Volume: 6 Issue: 3 Pages: 320-331
- DOI
  10.1158/2326-6066.cir-17-0386
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-17K07215, KAKENHI-PROJECT-17K07216, KAKENHI-PROJECT-15K09050, KAKENHI-PROJECT-15K09173
[Journal Article] A phase I clinical study of a cocktail vaccine of Wilms’ tumor 1 (WT1) HLA class I and II peptides for recurrent malignant glioma2018
- Author(s)
  Tsuboi A, Hashimoto N, Fujiki F, Morimoto S, Kagawa N, Nakajima H, Hosen N, Nishida S, Nakata J, Morita S, Sakamoto J, Oji Y, Oka Y, Sugiyama H
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 68(2) Issue: 2 Pages: 331-340
- DOI
  10.1007/s00262-018-2274-1
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-15K10331, KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-17K07215, KAKENHI-PROJECT-17K07216
[Journal Article] Wilms tumour 1 peptide vaccine as a cure-oriented post-chemotherapy strategy for patients with acute myeloid leukaemia at high risk of relapse.2017
- Author(s)
  Nakata J, Nakae Y, Kawakami M, Morimoto S, Motooka D, Hosen N, Fujiki F, Nakajima H, Hasegawa K, Nishida S, Tsuboi A, Oji Y, Oka Y, Kumanogoh A, Sugiyama H.
- Journal Title
  
  Br J Haematol.
  
  Volume: XX Issue: 2 Pages: 287-290
- DOI
  10.1111/bjh.14768
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-17K07216, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K09476, KAKENHI-PROJECT-15K19550
[Journal Article] Wilms’ tumor gene 1 (WT1) peptide vaccine therapy for hematological malignancies: from CTL epitope identification to recent progress in the clinical studies including a cure-oriented strategy.2017
- Author(s)
  Oka Y., Tsuboi A., Nakata J., Nishida S., Hosen N., Kumanogoh A., Oji Y., Sugiyama H.
- Journal Title
  
  Oncol Res Treat.
  
  Volume: 40 Issue: 11 Pages: 682-690
- DOI
  10.1159/000481353
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-15K09173
[Journal Article] Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide.2016
- Author(s)
  Oji Y, Hashimoto N, Tsuboi A, Murakami Y, Iwai M, Kagawa N, Chiba Y, Izumoto S, Elisseeva O, Ichinohasama R, Sakamoto J, Morita S, Nakajima H, Takashima S, Nakae Y, Nakata J, Kawakami M, Nishida S, Hosen N, Fujiki F, Morimoto S, Adachi M, Iwamoto M, Oka Y, Yoshimine T, Sugiyama H.
- Journal Title
  
  Int J Cancer.
  
  Volume: 139 Issue: 6 Pages: 1391-401
- DOI
  10.1002/ijc.30182
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25462257, KAKENHI-PROJECT-26430162, KAKENHI-PROJECT-26462195, KAKENHI-PROJECT-15K18446, KAKENHI-PROJECT-15K08609, KAKENHI-PROJECT-15K09173, KAKENHI-PROJECT-15K09476, KAKENHI-PROJECT-15K10331, KAKENHI-PROJECT-16K11136, KAKENHI-PROJECT-15K19550
[Journal Article] Wilms tumor 1 peptide vaccination after hematopoietic stem cell transplant in leukemia patients.2016
- Author(s)
  Hosen N, Maeda T, Hashii Y, Tsuboi A, Nishida S, Nakata J, Oji Y, Oka Y, Sugiyama H.
- Journal Title
  
  Stem Cell Investig.
  
  Volume: 3 Pages: 90-90
- DOI
  10.21037/sci.2016.11.08
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K11136
[Journal Article] Cancer Immunotherapy targeting WT1: Designing a protocol for WT1 peptide-based cancer vaccine.2016
- Author(s)
  Sumiyuki Nishida, Haruo Sugiyama
- Journal Title
  
  Springer Protocols
  
  Volume: 1467 Pages: 221-232
- DOI
  10.1007/978-1-4939-4023-3_19
- ISBN
  9781493940219, 9781493940233
- Data Source
  KAKENHI-PROJECT-16K11136
[Journal Article] Vaccination with WT-1 (Wilms' Tumor gene-1) peptide and BCG-CWS in melanoma2012
- Author(s)
  Nishioka M, Tanemura A, Nishida S, et al
- Journal Title
  
  Eur J Dermatol
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21790665
[Journal Article] WT1 Peptide Therapy for a Patient with Chemotherapy-resistant Salivary Gland Cancer2012
- Author(s)
  Shirakata T, Oka Y, Nishida S, et al
- Journal Title
  
  Anticancer Res
  
  Volume: 32 Pages: 1081-1085
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21790665
[Journal Article] Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response2011
- Author(s)
  Takahara A., Koido S., Nishida S., et al
- Journal Title
  
  Cancer Immunol Immunother
  
  Volume: 60 Pages: 1289-1297
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21790665
[Journal Article] WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML Patient2010
- Author(s)
  Oji Y, Oka Y, Nishida S, et al
- Journal Title
  
  Eur J Hematology
  
  Volume: 85 Pages: 358-360
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] Isolation of a novel high-avidity TCR in pancreatic cancer patients receiving the combination of WT1126 peptide vaccine plus gemcitabine2023
- Author(s)
  Soyoko Morimoto, Fumihiro Fujiki, Akinori Nagata, Satsuki Okafuji, Jun Nakata, Hiroko Nakajima, Akihiro Tsuboi, Yoshiko Hashii, Yoshihiro Oka, Yusuke Oji, Takeshi Ishikawa, Shinichi Egawa, Shingo Koido, Haruo Sugiyama, Sumiyuki Nishida
- Organizer
  The 10th International Conference on WT1 in human neoplasia
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K07251
[Presentation] GEM併用WT1ワクチン投与膵癌患者からのWT1126特異的high avidity TCRの単離2023
- Author(s)
  森本　創世子、藤木　文博、西田　純幸、永田　暁教、岡藤　咲月、中田　潤、中島　博子、岡　芳弘、尾路　祐介、杉山　治夫
- Organizer
  第15回日本血液疾患免疫療法学会
- Data Source
  KAKENHI-PROJECT-22K07251
[Presentation] TCF1レポーターマウスを活用した腫瘍局所と所属リンパ節に存在する癌抗原特異的CD8+ T細胞の分類と解析2023
- Author(s)
  永田　暁教、藤木　文博、森本　創世子、中田　潤、西田　純幸、中島　博子、橋井　佳子、坪井　昭博、岡　芳弘、尾路　祐介、杉山治夫
- Organizer
  第27回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K07251
[Presentation] GEM併用WT1ワクチン投与膵癌患者から単離したWT1126特異的high-avidity TCRのTCR-T細胞療法への応用2023
- Author(s)
  森本　創世子、藤木　文博、西田　純幸、永田　暁教、中田　潤、中島　博子、尾路　祐介、岡芳弘、杉山　治夫
- Organizer
  第51回日本臨床免疫学会総会
- Data Source
  KAKENHI-PROJECT-22K07251
[Presentation] 1.GEM併用WT1ワクチン投与膵癌患者からのWT1^126特異的high-avidity TCRの単離2022
- Author(s)
  森本創世子, 藤木文博, 西田純幸, 永田暁教, 中田潤, 中島博子, 尾路祐介, 岡芳弘, 杉山治夫
- Organizer
  日本臨床免疫学会
- Data Source
  KAKENHI-PROJECT-22K07251
[Presentation] WT1遺伝子産物を標的にしたがんワクチン療法の将来展望：がん治療からがん発症予防へ2021
- Author(s)
  西田　純幸
- Organizer
  日本がん予防医学会
- Data Source
  KAKENHI-PROJECT-19K07729
[Presentation] 進行卵巣癌に対するWT1を標的とした癌ワクチンに関する臨床研究(Clinical Study of the Cancer Vaccine targeting WT1 for Advanced Ovarian Cancer)2019
- Author(s)
  西田純幸, 白方俊章, 森本創世子, 榎本隆之, 吉野潔, 冨松拓治, 藤木文博, 尾路祐介, 上田豊, 坪井昭博, 森田智視, 岡芳弘, 熊ノ郷淳, 木村正, 杉山治夫
- Organizer
  日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-19K07729
[Presentation] 進行肺癌に対するCpG ODN(K3)皮下注射による自然免疫の活性化(Activation of innate immunity in patients with advanced lung cancer following subcutaneous injection of CpG ODN(K3))2019
- Author(s)
  大塚倫之, 西田純幸, 濱口眞成, 柴原理志, 白山敬之, 川合祥子, 木村恵子, 平田陽彦, 木田博, 石井健, 熊ノ郷淳
- Organizer
  日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-19K07729
[Presentation] Immunomonitoring fo Rare Cancer Patinets Treated with WT1 Trio Peptide-based Cancer Immunotherapy2018
- Author(s)
  Yusuke Oji, Miki Iwai, Sae Hayashi, Naoki Kagawa, Hideyuki Arita, Yasushi Shintani, Yoshito Takeda, Eiichi Morii, Kenichiro Hamada, Kenzo Shimazu, Motoyuki Suzuki, Hiroko Nakajima, Fumihiro Fujiki, Rin Imanishi, Kana Hasegawa, Soyoko Morimoto, Jun Nakata, Sumiyuki NIshida, et al
- Organizer
  9th International Conference on WT1 in Human Neoplasia
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11136
[Presentation] Establishment of a novel platform cell line for efficient and precise evaluation of T cell receptor functional avidity.2018
- Author(s)
  Soyoko Morimoto, Fumihiro Fujiki, Kenta Kondo, Hiroko Nakajima, Yoshiki Kobayashi, Miki Inatome, Nao Aoyama, Yuya Nishida, Akihiro Tsuboi, Yoshihiro Oka, Sumiyuki Nishida, Jun Nakata, Naoki Hosen, Yusuke Oji, Haruo Sugiyama
- Organizer
  9th International Conference on WT1 in Human Neoplasia
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11136
[Presentation] Randomized phases II study of WT1 peptide vaccine in combination with gemcitabine for advanced pancreaticcancer: association between clinical efficacy and immune response in metastatic pancreatic cancer patinets.2018
- Author(s)
  Sumiyuki Nishida, Soyoko Morimoto, Yoshihiro Oka, Shinichi Egawa, Takeshi Ishikawa, Shigeo Koido, Hiroaki Yasuda, Hiroaki Yanagimoto, Jun Ishii, Yoshihide Kanno, Atsushi Kumanogoh, Satoshi Morita, Haruo Sugiyama
- Organizer
  9th International Conference on WT1 in Human Neoplasia
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11136
[Presentation] 進行膵癌に対するWT1ペプチドワクチン併用化学療法無作為比較第II相試験2017
- Author(s)
  江川　新一、石川　剛、西田　純幸
- Organizer
  第103回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-16K11136
[Presentation] 切除不能進行膵癌に対するゲムシタビン併用HLA拘束性WT1ペプチドワクチン療法で誘導されたWT1特異的CTLの免疫学的機能解析2017
- Author(s)
  森本　創世子、西田　純幸、小井戸　薫雄、江川　新一、石川　剛、石井　淳、菅野　良秀、柳本　泰明、江口　英利、中田　潤、保仙　直毅、坪井　昭博、長谷川　加奈、中島　博子、藤木　文博、尾路　祐介、熊ノ郷　淳、岡　芳弘、杉山　治夫
- Organizer
  第21回　日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-16K11136
[Presentation] 進行膵癌に対するゲムシタビン併用WT1ワクチン療法ランダム化第II相臨床試験：臨床効果と抗原特異的免疫反応の評価2016
- Author(s)
  西田　純幸、石川　剛、江川　新一、小井戸　薫雄、森本　創世子、石井　淳、菅野　良秀、柳本　泰明、大庭　真梨、古倉　聡、本間　定、島田　英昭、森田　智視、岡　芳弘、杉山　治夫
- Organizer
  第20回日本がん免疫学会総会
- Place of Presentation
  大阪国際交流センター、大阪
- Year and Date
  2016-07-27
- Data Source
  KAKENHI-PROJECT-16K11136
[Presentation] An open-label phase II randomized trial of WT1 peptide vaccine plus gemcitabine for advanced pancreatic cancer2016
- Author(s)
  Takeshi Ishikawa, Sumiyuki Nishida, Shinichi Egawa, Shigeo Koido, Jun Ishii, Yoshihide Kanno, Hiroaki Yanagimoto, Satoshi Kokura, Soyoko Morimoto, Mari S. Oba, Yoshihiro Oka, and Haruo Sugiyama
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜、横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-16K11136
[Presentation] Randomized phases II study of WT1 peptide vaccine plus gemcitabine for advanced pancreatic ductal adenocarcinoma (PDAC): Clinical efficacy and immune response2016
- Author(s)
  Sumiyuki Nishida, Takeshi Ishikawa, Satoshi Kokura, Shinichi Egawa, Shigeo Koido, Hiroaki Yasuda, Hiroaki Yanagimoto, Jun Ishii, Yoshihide Kanno, Mari S. Ohba, Maho Sato, Soyoko Morimoto, Hidetoshi Eguchi, Hiroaki Nagano, Sadamu Homma, Yoshihiro Oka, Satoshi Morita, and Haruo Sugiyama
- Organizer
  ASCO Annual Meeting 2016
- Place of Presentation
  McCormick Place, Chicago, USA
- Year and Date
  2016-06-03
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K11136
[Presentation] WT1ペプチドを用いたがんの免疫療法多施設共同研究2011
- Author(s)
  西田純幸
- Organizer
  第24回日本バイオセラピー学会
- Place of Presentation
  ダイワロイヤルネットホテル和歌山(招待講演)
- Year and Date
  2011-11-30
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] Memory WT1-CTLs is a useful marker to predict the clinical outcome ; WT1 vaccine in the combination with gemcitabine2011
- Author(s)
  Nishida S
- Organizer
  第70回日本癌学会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] Memory WT1-CTLs is a useful marker to predict the clinical outcome ; WT1 vaccine in the combination with gemcitabine2011
- Author(s)
  Nishida S
- Organizer
  日本癌学会
- Place of Presentation
  名古屋国際会議場(愛知県)
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] Cancer immunotherapy combined with chemotherapy for pancreatic cancer ; a phase 1 clinical trial of the combination therapy with gemcitabine and WT1-peptide-based cancer vaccine2011
- Author(s)
  Nishida S
- Organizer
  第9回日本臨床腫瘍学会
- Place of Presentation
  横浜パシフィコ(招待講演)
- Year and Date
  2011-07-22
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] WT1ペプチドを用いたがんの免疫療法多施設共同研究2011
- Author(s)
  西田純幸
- Organizer
  日本バイオセラピー学会
- Place of Presentation
  ダイワロイヤルネットホテル和歌山(和歌山県)
- Year and Date
  2011-11-30
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] WT1 PEPTIDE-BASED CANCER VACCINE IN COMBINATION WITH GEMCITABINE IN PATIENTS WITH ADVANCED PANCREATIC CANCER-PHASE 1 CLINICAL TRIAL2011
- Author(s)
  S. Nishida
- Organizer
  5^<th> International conference on WT1 in Human Neoplasia
- Place of Presentation
  Italy Turin
- Year and Date
  2011-04-15
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] WT1 PEPTIDE-BASED CANCER VACCINE IN COMBINATION WITH GEMCITABINE IN PATIENTS WITH ADVANCED PANCREATIC CANCER-PHASE 1 CLINICAL TRIAL-2011
- Author(s)
  Nishida S
- Organizer
  The 5^<th> International Conference on WT1 In Human Neoplasia
- Place of Presentation
  イタリア・トリノ(招待講演)
- Year and Date
  2011-04-15
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] Cancer immunotherapy combined with chemotherapy for pancreatic cancer ; a phase 1 clinical trial of the combination therapy with gemcitabine and WT1-peptide-based cancer vaccine2011
- Author(s)
  S. Nishida
- Organizer
  日本臨床腫瘍学会
- Place of Presentation
  横浜パシフィコ(神奈川県)
- Year and Date
  2011-07-22
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] A Phase I study of WT1 peptide-based cancer vaccine combined with Gemcitabine for Advanced Pancreatic Cancer2010
- Author(s)
  S. Nishida
- Organizer
  日本癌学会
- Place of Presentation
  大阪国際会議場(大阪府)
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] Phase I clinical trial of WT1 peptide-based cancer vaccine in combination with gemcitabine in patients with advanced pancreatic cancer2010
- Author(s)
  西田純幸
- Organizer
  9^<th> Asia Clinical Oncology Society
- Place of Presentation
  岐阜市(招待講演)
- Year and Date
  2010-08-25
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] A Phase I study of WT1 peptide-based cancer vaccine combined with Gemcitabine for Advanced Pancreatic Cancer2010
- Author(s)
  西田純幸
- Organizer
  第69回日本癌学会
- Place of Presentation
  大阪市
- Year and Date
  2010-09-22
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] Phase I clinical trial of WT1 peptide-based cancer vaccine in combination with gemcitabine in patients with advanced pancreatic cancer2010
- Author(s)
  S. Nishida
- Organizer
  Asia Clinical Oncology Society
- Place of Presentation
  岐阜グランドホテル(岐阜県)
- Year and Date
  2010-08-26
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] WT1ペプチドワクチン療法の癌に対する集学的治療への仲間入りを目指した臨床研究2010
- Author(s)
  西田純幸
- Organizer
  日本がん免疫学会
- Place of Presentation
  KKRホテル熊本(熊本県)
- Year and Date
  2010-07-23
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] WT1ペプチドワクチン療法の癌に対する集学的治療への仲間入りを目指した臨床研究2010
- Author(s)
  西田純幸
- Organizer
  第14回日本がん免疫学会
- Place of Presentation
  熊本市
- Year and Date
  2010-07-22
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] WT1ペプチドワクチンと塩酸ゲムシタビンを併用した進行膵臓癌に対する新たな治療戦略2009
- Author(s)
  西田純幸
- Organizer
  日本癌免疫学会
- Place of Presentation
  北九州国際会議場(福岡県)
- Year and Date
  2009-06-24
- Data Source
  KAKENHI-PROJECT-21790665
[Presentation] 進行膵臓癌に対するゲムシタビン併用WT1ペプチドワクチン療法2009
- Author(s)
  西田純幸
- Organizer
  日本癌学会
- Place of Presentation
  横浜パシフィコ(神奈川県)
- Data Source
  KAKENHI-PROJECT-21790665

1. 森本創世子 (10649023)

# of Collaborated Projects: 2 results

# of Collaborated Products: 17 results
2. TSUBOI Akihiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. CHIBA Yasuyoshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. KIDA Hiroshi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. FUJIKI Fumihiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
6. HOSEN Naoki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. KAGAWA Naoki

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
8. 橋本直哉

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 井上義一

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Nishida Sumiyuki 西田 純幸

NISHIDA Sumiyuki 西田 純幸

Research Projects

Research Products

Co-Researchers

難治がんに有望ながん免疫effector T細胞特性の基盤的解明と細胞治療開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Cellular and Molecular analyses of cancer-associated antigen-specific cytotoxic T cells by multidimensional methods and development of novel cancer immunotherapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of WT1 peptide vaccine for ovarian cancer and analyses of WT1-CTLsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

WT1-specific immunological assessments in WT1-peptide-based cancer vaccine in combination with gemcitabine for patients with advanced pancreatic cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Overexpression of the WT1 gene effects on proliferation ofhematopoietic stem cells, and promotes leukemogenesisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Establishment of a novel NFAT-GFP reporter platform useful for the functional avidity maturation of HLA class II-restricted TCRs2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Bayesian predictive model averaging approach to joint longitudinal-survival modeling: Application to an immuno-oncology clinical trial.2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT12023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cellular and Humoral Immune Responses Induced by an HLA Class I-restricted Peptide Cancer Vaccine Targeting WT1 Are Associated With Favorable Clinical Outcomes in Advanced Ovarian Cancer.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] WT1 epitope-specific IgG and IgM antibodies for immune-monitoring in patients with advanced sarcoma treated with a WT1 peptide cancer vaccine.2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] T Cell-Intrinsic Vitamin A Metabolism and Its Signaling Are Targets for Memory T Cell-Based Cancer Immunotherapy2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Immune adjuvant therapy using Bacillus Calmette-Gu&eacute;rin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] WT1 peptide-based immunotherapy for advanced thymic epithelial malignancies2018

Author(s)

Journal Title

DOI

Data Source

Nishida Sumiyuki 西田純幸

NISHIDA Sumiyuki 西田純幸

[Journal Article] Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.2019